Nutromics is an award-winning Australian MedTech company that is developing a Continuous Molecular Monitoring (CMM) platform technology that is used in combination with aptamer-based wearable sensors. Our vision is to create a world with zero preventable deaths due to a lack of timely molecular-level patient data.